secwatch / observer
8-K filed March 19, 2024, 7:59 PM ET ticker SYBX CIK 0001527599
earnings confidence high sentiment negative materiality 0.85

Synlogic discontinues PKU program; Q4 net loss $14.5M, cash $47.7M

SYNLOGIC, INC.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SYNLOGIC, INC. reported the year ended December 31, 2023 results: revenue $3.4 million, net income $57.3 million, EPS $8.81 per share.

Period
the year ended December 31, 2023
Revenue
$3.4 million
Net income
$57.3 million
EPS
$8.81 per share
Result
reported results
Exact text from the filing
$1.71 per share, compared to a consolidated net loss of $16.7 million, or $3.54 per share, for the corresponding period in 2022. Full Year 2023 Financial Results Revenues were $3.4 million for the year ended December 31, 2023, compared to $1.2 million for the same period in 2022. Revenue in both periods was associated with the research collaboration with Roche.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SYNLOGIC, INC. reported the quarter ended December 31, 2023 results: revenue $2.8 million, net income $14.5 million, EPS $1.71 per share.

Period
the quarter ended December 31, 2023
Revenue
$2.8 million
Net income
$14.5 million
EPS
$1.71 per share
Result
reported results
Exact text from the filing
Company. Fourth Quarter 2023 Financial Results As of December 31, 2023, Synlogic had cash, cash equivalents, and short-term marketable securities of $47.7 million. Revenue was $2.8 million for the three months ended December 31, 2023, compared to $0.1 million for the corresponding period in 2022. Revenue in both periods was associated with the research
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

SYNLOGIC, INC. filing history →

Source: SEC EDGAR
accession 0000950170-24-033145
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.